Cargando…

Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use

Detalles Bibliográficos
Autores principales:	Koopaei, Nasser Nassiri, Abdollahi, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105287/ https://www.ncbi.nlm.nih.gov/pubmed/27832818 http://dx.doi.org/10.1186/s40199-016-0164-7

Ejemplares similares

Opportunities and obstacles to the development of nanopharmaceuticals for human use
por: Nassiri Koopaei, Nasser, et al.
Publicado: (2016)

Nanopharmaceutics
por: Ali, Javed
Publicado: (2011)

Health risks associated with the pharmaceuticals in wastewater
por: Nassiri Koopaei, Nasser, et al.
Publicado: (2017)

Trends in Nanopharmaceutical Patents
por: Antunes, Adelaide, et al.
Publicado: (2013)

Use of Protamine in Nanopharmaceuticals—A Review
por: Ruseska, Ivana, et al.
Publicado: (2021)

Antimicrobial resistance in human populations: challenges and opportunities – ERRATUM
por: Allcock, S., et al.
Publicado: (2017)

The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016
por: Zartab, Saman, et al.
Publicado: (2020)

Nanopharmaceuticals (part 1): products on the market
por: Weissig, Volkmar, et al.
Publicado: (2014)

Nanopharmaceuticals (part 2): products in the pipeline
por: Weissig, Volkmar, et al.
Publicado: (2015)

Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
por: Salama, Lavinia, et al.
Publicado: (2020)

Erratum to: Precision medicine approaches for diabetic kidney disease: opportunities and challenges
por: Tye, Sok Cin, et al.
Publicado: (2022)

Erratum to “Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities”
por: Kasal, Daniel Arthur B., et al.
Publicado: (2012)

Erratum to: Communities of practice for supporting health systems change: a missed opportunity
por: Kothari, Anita, et al.
Publicado: (2015)

Erratum to: Women-only drug treatment services and needs in Iran: the first review of current literature
por: Alam-mehrjerdi, Zahra, et al.
Publicado: (2016)

Nanopharmaceuticals for Eye Administration: Sterilization, Depyrogenation and Clinical Applications
por: Zielińska, Aleksandra, et al.
Publicado: (2020)

Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications
por: Zielińska, Aleksandra, et al.
Publicado: (2021)

Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment
por: Lee, Hyeji, et al.
Publicado: (2022)

Erratum: Different applications of telemedicine-assessing the challenges, barriers, and opportunities-a narrative review
Publicado: (2022)

CRLX101 (formerly IT-101)–A Novel Nanopharmaceutical of Camptothecin in Clinical Development
por: Young, Cissy, et al.
Publicado: (2011)

Erratum to: Treating the invisible: Gaps and opportunities for enhanced TB control along the Thailand-Myanmar border
por: Tschirhart, Naomi, et al.
Publicado: (2017)

Erratum: “Identifying and Prioritizing Chemicals with Uncertain Burden of Exposure: Opportunities for Biomonitoring and Health-Related Research”
por: Pellizzari, Edo D., et al.
Publicado: (2020)

Erratum: Identifying and Prioritizing Chemicals with Uncertain Burden of Exposure: Opportunities for Biomonitoring and Health-Related Research
por: Pellizzari, Edo D., et al.
Publicado: (2021)

Erratum: New Developments at EHP
Publicado: (2015)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)

Erratum to: Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys
por: Jagessar, S. Anwar, et al.
Publicado: (2012)

Erratum to Circular RNAs and human glioma
por: Jinglei, Liu, et al.
Publicado: (2020)

Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
por: Ahmed, Osama A. A., et al.
Publicado: (2020)

Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods
por: Souto, Eliana B., et al.
Publicado: (2020)

Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals
por: Thiyagarajan, Durairaj, et al.
Publicado: (2021)

Erratum to development and formulation of the classification criteria for osteoarthritis
por: Huang, Cibo, et al.
Publicado: (2020)

Erratum: Correction of Title
por: Shojaei Zarghani, Sara, et al.
Publicado: (2021)

Erratum: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies
Publicado: (2017)

Synthesis and Analgesic Activity of Novel Hydrazide and Hydrazine Derivatives
por: Nassiri Koopaei, Mansur, et al.
Publicado: (2013)

Erratum: Obesity changes the human gut mycobiome
por: Mar Rodríguez, M., et al.
Publicado: (2016)

Erratum to ‘Bateman's principles and human sex roles’
por: Brown, Gillian R., et al.
Publicado: (2013)

Erratum to “Endocytosis of Integrin-Binding Human Picornaviruses”
por: Merilahti, Pirjo, et al.
Publicado: (2013)

Erratum: Initial sequencing and analysis of the human genome
Publicado: (2001)

Erratum: Associations between Dietary Allium Vegetables and Risk of Breast Cancer: A Hospital-Based Matched Case-Control Study
por: Pourzand, Ali, et al.
Publicado: (2018)

CAEP Position Statement – Management of devastating brain injuries in the emergency department: Enhancing neuroprognostication and maintaining the opportunity for organ and tissue donation – ERRATUM
por: Healey, Andrew, et al.
Publicado: (2020)

Erratum to “Progress in Therapy Development for Amyotrophic Lateral Sclerosis”
por: Venkova-Hristova, Kalina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_54bg250sqp1fpgni0n5v5tciep